SAFECODE DRUG TECHNOLOGIES CORP.
company.status.inactiveCIK 1508470fmd_168W9NRTPHRQVQD21ZVTTWJY8RManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2011 to Jun 30, 2013, 10 periods
Latest annual · FY2012
Millions- Total revenues
- 0
- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q1 FY2013
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Bulls and bears
Loading
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
SAFECODE DRUG TECHNOLOGIES CORP. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2013-03-25 · proof | |
| Operating income | -$2 million | -$41,856 | 10-K 2013-03-25 · proof | |
| Net income | -$2.1 million | -$41,856 | 10-K 2013-03-25 · proof | |
| Cash from operating activities | -$98,137 | -$23,909 | 10-K 2013-03-25 · proof | |
| Total assets | $174,333 | $20,000 | +771.7% | 10-K 2013-03-25 · proof |
| Total liabilities | $61,670 | $70,617 | -12.7% | 10-K 2013-03-25 · proof |
| Cash and cash equivalents | $0 | $0 | 10-K 2013-03-25 · proof |
- What was SAFECODE DRUG TECHNOLOGIES CORP.'s revenue in fiscal 2012?
- SAFECODE DRUG TECHNOLOGIES CORP. reported revenue of $0 for fiscal 2012 (the year ended Dec 31, 2012), against $0 the year before. Source: the 10-K filed with the SEC on Mar 25, 2013. SEC
- What was SAFECODE DRUG TECHNOLOGIES CORP.'s operating income in fiscal 2012?
- SAFECODE DRUG TECHNOLOGIES CORP. reported operating income of -$2 million for fiscal 2012 (the year ended Dec 31, 2012), against -$41,856 the year before. Source: the 10-K filed with the SEC on Mar 25, 2013. SEC
- What was SAFECODE DRUG TECHNOLOGIES CORP.'s net income in fiscal 2012?
- SAFECODE DRUG TECHNOLOGIES CORP. reported net income of -$2.1 million for fiscal 2012 (the year ended Dec 31, 2012), against -$41,856 the year before. Source: the 10-K filed with the SEC on Mar 25, 2013. SEC
- What was SAFECODE DRUG TECHNOLOGIES CORP.'s cash from operating activities in fiscal 2012?
- SAFECODE DRUG TECHNOLOGIES CORP. reported cash from operating activities of -$98,137 for fiscal 2012 (the year ended Dec 31, 2012), against -$23,909 the year before. Source: the 10-K filed with the SEC on Mar 25, 2013. SEC
- What are SAFECODE DRUG TECHNOLOGIES CORP.'s total assets?
- As of Dec 31, 2012, SAFECODE DRUG TECHNOLOGIES CORP. reported total assets of $174,333, against $20,000 a year earlier (+771.7%). Source: the 10-K filed with the SEC on Mar 25, 2013. SEC
- What are SAFECODE DRUG TECHNOLOGIES CORP.'s total liabilities?
- As of Dec 31, 2012, SAFECODE DRUG TECHNOLOGIES CORP. reported total liabilities of $61,670, against $70,617 a year earlier (-12.7%). Source: the 10-K filed with the SEC on Mar 25, 2013. SEC
- What are SAFECODE DRUG TECHNOLOGIES CORP.'s cash and cash equivalents?
- As of Dec 31, 2012, SAFECODE DRUG TECHNOLOGIES CORP. reported cash and cash equivalents of $0, against $0 a year earlier. Source: the 10-K filed with the SEC on Mar 25, 2013. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1508470&period_type=annual&limit=5"Information only, not investment advice.